News
CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer's XELJANZ ® (tofacitinib citrate) Pfizer Plans to Work with the European Medicines Agency (EMA) to Resubmit Marketing ...
CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer's XELJANZ ® (tofacitinib citrate) Pfizer Plans to Work with the European Medicines Agency (EMA) to Resubmit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback